| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
XinYue International Ltd.
|
94.095m | 13.95% | +503.000k | Apr 30 2026 |
| 2 |
Lilly Asia Ventures
|
46.845m | 6.94% | — | Dec 31 2025 |
| 3 |
Hillhouse Investment Management Limited
|
40.739m | 6.04% | — | Dec 31 2025 |
| 4 |
Zhang (Yi)
|
38.150m | 5.65% | — | Apr 30 2026 |
| 5 |
FIL Investment Management (Hong Kong) Limited
|
37.754m | 5.60% | — | Dec 31 2024 |
|
1
XinYue International Ltd.
|
13.95%
94.095m
|
|
2
Lilly Asia Ventures
|
6.94%
46.845m
|
|
3
Hillhouse Investment Management Limited
|
6.04%
40.739m
|
|
4
Zhang (Yi)
|
5.65%
38.150m
|
|
5
FIL Investment Management (Hong Kong) Limited
|
5.60%
37.754m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 38.18% of Peijia Medical, with XinYue International Ltd. the biggest at 13.95%, followed by Lilly Asia Ventures (6.94%) and Hillhouse Investment Management Limited (6.04%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


